Have you noticed that our world is filled with continual threats of terrorism accompanied by accelerated loss of rights and liberties? If this reality bothers you then you need to get your FREE copy of this provocative book!
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, recently provided the...
Kyocera will be highlighting its wide range of ceramics-based technologies at MD&M West Medical Expo in Anaheim, Calif., February 11-13, 2020, the world's largest annual convention for medical product designers and manufacturers.
There is so much going on about coronavirus. Now we can see about which planets are responsible for causing this problem, when we will get the right vaccine for this virus.
The United States Patent and Trademark Office (USPTO) has issued a patent on NLX-112, a drug candidate developed by Neurolixis for treatment of human movement disorders, notably levodopa-induced dyskinesia in Parkinson's disease.
Rubix LS Isolated Protein Binding Receptors in Ebola and Leishmaniasis Providing Rapid Spectral Analysis of Key Proteins in Real Time Its Technology Now Being Fit to Target Coronavirus
OnLume Inc., ("OnLume"), a medical device company developing novel imaging systems for use during surgery, announced that it had received 510(k) clearance from the U.S.
- Ms. Hermans will exchange views on measuring patient empowerment in clinical trial recruitment - Panel will cover vendor performance metrics and KPIs, as part of outsourcing and strategic partnerships in clinical trials - Insights from 83bar experience.
A market maker has filed a Form 211 Application with the Financial Industry Regulatory Authority ("FINRA") to request permission to quote and trade the securities of CEN Biotech, Inc. ("CEN Biotech" or the "Company") on OTC Markets.
Faster and easier business rule engine allows life science companies to make and deploy changes faster so they can be more responsive to market needs and regulatory changes.
Digital health venture funding remains near all-time highs. Startups in the sector are on track to raise $7.3B by the end of the year — over a 25% compounded annual growth rate since 2011.
BioLink Life Sciences is pleased to announce that it recently had its patent application allowed by the USPTO for the composition, use and formulation of Strontium SR.
- New QMS and ISMS bring 83bar in compliance with ISO9001 and ISO27001 certifications - Demonstrates commitment to quality management and safeguarding data
Molecular Depot introduces a new Anti IgM Antibody Monoclonal. Mouse monoclonal antibody to Human Mu-chain IgM antibody. This antibody can be used in the detection or blocking of human IgM antibodies as well as in WB applications.
Molecular Depot introduces a new antibody that is specific to Biotin: Monoclonal Mouse Anti-Biotin Antibody. Biotin is a water-soluble B vitamin involved in the metabolism of lipids, carbohydrates and amino acids.
Biotech Support Group reports on a recent journal article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching the red cell proteome, to study post-translational modifications in erythrocytic diseases.
Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching the red cell proteome, in order to measure autoantibodies to band 3 protein in cancer patient...
Have you noticed that our world is filled with continual threats of terrorism accompanied by accelerated loss of rights and liberties? If this reality bothers you then you need to get your FREE copy of this provocative book!
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, recently provided the...
Kyocera will be highlighting its wide range of ceramics-based technologies at MD&M West Medical Expo in Anaheim, Calif., February 11-13, 2020, the world's largest annual convention for medical product designers and manufacturers.
Molecular Depot is proud to be the only marketplace providing a key component of the a-complementation system: the beta-galactosidase Enzyme Donor (ED).
There is so much going on about coronavirus. Now we can see about which planets are responsible for causing this problem, when we will get the right vaccine for this virus.
PHILADELPHIA, Feb. 6, 2020 – Pinpoint Therapeutics, Inc. ("Pinpoint"), a privately held biopharmaceutical company focused on the development of novel autophagy inhibitors to treat cancer, announced that it has raised $1 million in debt financing led by...
The United States Patent and Trademark Office (USPTO) has issued a patent on NLX-112, a drug candidate developed by Neurolixis for treatment of human movement disorders, notably levodopa-induced dyskinesia in Parkinson's disease.
Molecular Depot introduces the latest product in its new collection of mouse monoclonal antibodies: Anti AFP antibodies. Alpha-Fetoprotein (AFP) is a protein essentially produced during the fetal stages of human development.
Rubix LS Isolated Protein Binding Receptors in Ebola and Leishmaniasis Providing Rapid Spectral Analysis of Key Proteins in Real Time Its Technology Now Being Fit to Target Coronavirus
OnLume Inc., ("OnLume"), a medical device company developing novel imaging systems for use during surgery, announced that it had received 510(k) clearance from the U.S.
- Ms. Hermans will exchange views on measuring patient empowerment in clinical trial recruitment - Panel will cover vendor performance metrics and KPIs, as part of outsourcing and strategic partnerships in clinical trials - Insights from 83bar experience.
A market maker has filed a Form 211 Application with the Financial Industry Regulatory Authority ("FINRA") to request permission to quote and trade the securities of CEN Biotech, Inc. ("CEN Biotech" or the "Company") on OTC Markets.
Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large collections of compounds in singular reaction tubes, capturing the attention of small and big pharma players
Molecular Depot now offers a high purity, high quality, enzyme: Ascorbate Oxidase. Ascorbate oxidase catalyzes the following reaction: Ascorbic acid + 1/2 O2 → Dehydroascorbic acid + H2O.
Molecular Depot introduces a new antibody to human Myoglobin. Myoglobin is an oxygen-binding protein found in muscle cells, including heart muscle cells. This polyclonal antibody targets specifically human Myoglobin found in heart cells.
Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating rare cells from heterogenous cell populations.
An overview of the current market landscape, featuring a comprehensive list of over 150 active contract services / technology providers, and a detailed analysis based on a number of parameters.
